← back to search

Wei Yan

Anhui Medical University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Glioma and microRNA, with related work in Hippo signaling pathway, Ectopic expression, Oncogene. Notable publications include 'An overview of signaling pathways regulating YAP/TAZ activity', 'Role of YAP/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways', and 'miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2'.
h-index
citations
743
works
9
NIH funding
primary concept
email

Recent publications

An overview of signaling pathways regulating YAP/TAZ activity
Cellular and Molecular Life Sciences 2020cited by 132position: middledoi
Role of YAP/TAZ in Cell Lineage Fate Determination and Related Signaling Pathways
Frontiers in Cell and Developmental Biology 2020cited by 122position: middledoi
Identification of miRNA-Mediated Core Gene Module for Glioma Patient Prediction by Integrating High-Throughput miRNA, mRNA Expression and Pathway Structure
PLoS ONE 2014cited by 27position: middledoi
Corrigendum to “miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2” [Eur J Cancer 48(16) (2012) 3104–3111]
European Journal of Cancer 2013cited by 9position: middledoi
miR-137 is frequently down-regulated in glioblastoma and is a negative regulator of Cox-2
European Journal of Cancer 2012cited by 107position: middledoi
MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1
Oncology Reports 2012cited by 104position: middledoi
Whole‐genome microRNA expression profiling identifies a 5‐microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme
Cancer 2012cited by 96position: middledoi
The Putative Tumor Suppressor miR-524–5p Directly Targets Jagged-1 and Hes-1 in Glioma
Carcinogenesis 2012cited by 80position: middledoi
MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling
Cancer Letters 2012cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Chunsheng Kang · Tianjin Medical University General Hospital7 papers (2012–2014)Yongzhi Wang · Capital University5 papers (2012–2013)Lingchao Chen · Fudan University5 papers (2012–2013)Tao Jiang · Xinjiang Medical University5 papers (2012–2014)Kailiang Zhang · Shandong University4 papers (2012–2013)Peiyu Pu · Ministry of Education of the People's Republic of China4 papers (2012–2013)Lei Han · Ministry of Education of the People's Republic of China4 papers (2012–2014)Gan You · Beijing Tian Tan Hospital3 papers (2012–2014)Chuanlu Jiang · Fudan University3 papers (2012–2012)Zhaoshi Bao · Harbin Medical University3 papers (2012–2014)Wei Zhang · Central South University3 papers (2012–2014)Yongli Li · Fudan University3 papers (2012–2012)Junxia Zhang · Jiangsu Cancer Hospital2 papers (2012–2012)Chuanlu Jiang · Harbin Medical University2 papers (2012–2013)Boon Chin Heng · King University2 papers (2020–2020)Xiaochan Li · King University2 papers (2020–2020)Feng Yan · State Key Laboratory of Hydrology-Water Resources and Hydraulic Engineering2 papers (2012–2013)Dominique Aubel · Université Claude Bernard Lyon 12 papers (2020–2020)Martin Fussenegger · University of Basel2 papers (2020–2020)Xuliang Deng · King University2 papers (2020–2020)